These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 21354571

  • 1. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
    Sehestedt T, Lyngbæk S, Eugen-Olsen J, Jeppesen J, Andersen O, Hansen TW, Linneberg A, Jørgensen T, Haugaard SB, Olsen MH.
    Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
    [Abstract] [Full Text] [Related]

  • 2. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH, Christensen MK, Hansen TW, Gustafsson F, Rasmussen S, Wachtell K, Borch-Johnsen K, Ibsen H, Jørgensen T, Hildebrandt P.
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [Abstract] [Full Text] [Related]

  • 3. CRP and suPAR are differently related to anthropometry and subclinical organ damage.
    Lyngbæk S, Sehestedt T, Marott JL, Hansen TW, Olsen MH, Andersen O, Linneberg A, Madsbad S, Haugaard SB, Eugen-Olsen J, Jeppesen J.
    Int J Cardiol; 2013 Aug 10; 167(3):781-5. PubMed ID: 22459389
    [Abstract] [Full Text] [Related]

  • 4. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M, Engström G, Björkbacka H, Hedblad B.
    Atherosclerosis; 2012 Feb 10; 220(2):502-5. PubMed ID: 22119508
    [Abstract] [Full Text] [Related]

  • 5. Risk prediction is improved by adding markers of subclinical organ damage to SCORE.
    Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt P, Olsen MH.
    Eur Heart J; 2010 Apr 10; 31(7):883-91. PubMed ID: 20034972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
    Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH.
    J Hypertens; 2009 Jun 10; 27(6):1165-71. PubMed ID: 19387364
    [Abstract] [Full Text] [Related]

  • 8. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S, Lyngbaek S, Hansen TW, Eugen-Olsen J, Fenger M, Rossing P, Jeppesen JL.
    J Intern Med; 2015 Mar 10; 277(3):362-371. PubMed ID: 24830873
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
    J Hypertens; 2008 Jan 10; 26(1):26-34. PubMed ID: 18090537
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
    Diederichsen MZ, Diederichsen SZ, Mickley H, Steffensen FH, Lambrechtsen J, Sand NPR, Christensen KL, Olsen MH, Diederichsen A, Grønhøj MH.
    Atherosclerosis; 2018 Apr 10; 271():245-251. PubMed ID: 29402404
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
    Samman Tahhan A, Hayek SS, Sandesara P, Hajjari J, Hammadah M, O'Neal WT, Kelli HM, Alkhoder A, Ghasemzadeh N, Ko YA, Aida H, Gafeer MM, Abdelhadi N, Mohammed KH, Patel K, Arya S, Reiser J, Vaccarino V, Sperling L, Quyyumi A.
    Atherosclerosis; 2017 Sep 10; 264():108-114. PubMed ID: 28728756
    [Abstract] [Full Text] [Related]

  • 13. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G, Corban MT, Hung OY, Eshtehardi P, Eapen DJ, Al-Kassem H, Rasoul-Arzrumly E, Gogas BD, McDaniel MC, Pielak T, Thorball CW, Sperling L, Quyyumi AA, Samady H.
    Atherosclerosis; 2015 Mar 10; 239(1):55-60. PubMed ID: 25574858
    [Abstract] [Full Text] [Related]

  • 14. Descriptive study of the relationship between the subclinical carotid disease and biomarkers, carotid femoral pulse wave velocity in patients with hypertension.
    Zhao X, Bo L, Zhao H, Li L, Zhou Y, Wang H.
    Clin Exp Hypertens; 2018 Mar 10; 40(3):274-280. PubMed ID: 29227169
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score.
    Lyngbæk S, Marott JL, Sehestedt T, Hansen TW, Olsen MH, Andersen O, Linneberg A, Haugaard SB, Eugen-Olsen J, Hansen PR, Jeppesen J.
    Int J Cardiol; 2013 Sep 10; 167(6):2904-11. PubMed ID: 22909410
    [Abstract] [Full Text] [Related]

  • 16. suPAR: A New Biomarker for Cardiovascular Disease?
    Hodges GW, Bang CN, Wachtell K, Eugen-Olsen J, Jeppesen JL.
    Can J Cardiol; 2015 Oct 10; 31(10):1293-302. PubMed ID: 26118447
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.
    Edsfeldt A, Nitulescu M, Grufman H, Grönberg C, Persson A, Nilsson M, Persson M, Björkbacka H, Gonçalves I.
    Stroke; 2012 Dec 10; 43(12):3305-12. PubMed ID: 23150653
    [Abstract] [Full Text] [Related]

  • 19. Can ambulatory blood pressure measurements substitute assessment of subclinical cardiovascular damage?
    Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Olsen MH.
    J Hypertens; 2012 Mar 10; 30(3):513-21. PubMed ID: 22241138
    [Abstract] [Full Text] [Related]

  • 20. Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease.
    Persson M, Östling G, Smith G, Hamrefors V, Melander O, Hedblad B, Engström G.
    Stroke; 2014 Jan 10; 45(1):18-23. PubMed ID: 24253546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.